Adventures in HousingI've Always Wondered ...My EconomyTrump's Second Term

Loading...

0:00
0% played
This Giving Tuesday, Investor Dr. Rush is matching your donations to Marketplace - can we count on your support? Count Me In! ✔
Stories Tagged as

Pfizer

COVID-19

Uncertain demand for COVID shots imposes risk-benefit calculations on doctors

by Jackie Fortiér
Sep 2, 2024
Some pediatricians say they’re keeping their stockpiles low to avoid being stuck with costly, unwanted vaccines.
The waiting room at Dr. Eric Ball’s office in Orange County, California. Low demand has pediatricians carefully weighing how many costly COVID vaccinations to order.
Jackie Fortiér/KFF Health News
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE
COVID-19

COVID-19 economy wanes along with pandemic's urgency

by Meghan McCarty Carino
Oct 17, 2023
Makers of vaccines, tests and even protective gear are struggling to adjust to slackening demand.
Pharmaceutical giant Pfizer, which supplied key products in the battle against the coronavirus, has seen a dramatic reversal of fortune.
Michael M. Santiago/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE
COVID-19

Will FDA approval bring a wave of vaccine mandates?

by Matt Levin
Aug 23, 2021
Mandates will be detrimental to employers in a tight job market.
The Pfizer COVID-19 vaccine received full FDA approval Monday. Though more employers may mandate vaccines, more employees may voluntarily get them.
Patrick T. Fallon/AFP via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE
COVID-19

The upside of the vaccine rollout for the companies making shots

by Andy Uhler
May 3, 2021
The resulting goodwill may prove useful to Pfizer and Moderna.
Karen Andersen, who covers biotech at Morningstar, says the potential sale of booster shots to ward off variants of COVID-19 could be profitable for Pfizer and Moderna.
Matic Zorman/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE
Fast-Track Vaccines

Simmering tensions over EU vaccine distribution threaten to boil over

by Victoria Craig
Jan 27, 2021
The 27-nation bloc is battling with manufacturers over its spot in the priority list for receiving COVID vaccines.
Joel Saget/AFP via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE
Fast-Track Vaccines

The cost of "vaccine nationalism": $9 trillion

by Victoria Craig
Jan 26, 2021
With shortfalls in vaccine supplies, countries across the world are concerned about getting their fair share of doses.
A health worker carries syringes to administer Pfizer COVID-19 vaccines at the opening of a new vaccination site at Corsi Houses in Harlem, New York, on Jan. 15.
Kena Betancur/AFP via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE
COVID-19

Could relaxing patents help poorer countries get vaccines faster?

by Jasmine Garsd
Dec 15, 2020
India, South Africa, and Kenya want to try. The U.S., EU and U.K. aren't interested.
A medical worker administers the Pfizer BioNtech COVID-19 vaccine to a doctor at a hospital in Miami on Dec. 15.
Joe Raedle/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

For public good, not for profit.

Donate
COVID-19

Dry ice makers pressed to meet demand for vaccine distribution

by Erika Beras
Dec 11, 2020
Supercold storage is essential. But Is there enough dry ice to go around as the coronavirus vaccine is shipped around the country?
An employee makes dry ice pellets at Capitol Carbonic, a dry ice factory, in Baltimore, Maryland, in November.
Saul Loeb/AFP via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE
COVID-19

Vaccine delivery across the country faces complex supply chain challenges

by Scott Tong
Dec 10, 2020
Within 24 hours of emergency authorization from the Food and Drug Administration, the vaccine maker Pfizer plans to move the product to patients nationwide.
A worker prepares boxes of vaccines before shipment at a French pharmaceutical company world distribution center.
Joel Saget/AFP via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE
Fast-Track Vaccines

U.K. is first to green light Pfizer-BioNTech COVID-19 vaccine

by Victoria Craig
Dec 2, 2020
Fifty U.K. hospitals are on standby to administer vaccine shots, which will be available by next week.
U.K. regulators were the first in the world to approve the coronavirus vaccine made by Pfizer and BioNTech for widespread use.
Vincent Kalut/Photonews via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE